Pharmaceutical Majors Plan U.S. Manufacturing Investment Amid White House Push

September 23, 2025--Researched by Industrial Info Resources (Sugar Land, Texas)--As the White House aims to boost domestic manufacturing capacity of pharmaceuticals, industry giants are announcing capital investment in the U.S. Eli Lilly and Company (Indianapolis, Indiana) recently said it plans to build a $5 billion manufacturing facility in Virginia--the first of four planned manufacturing sites in the U.S.--and GSK plc (London, United Kingdom) announced plans to invest $30 billion in U.S. research and development (R&D) and manufacturing over the next five years.